Elevations in Creatine Kinase are Not Related to the Choice or Dose of Statins in Patients Taking Colchicine 0.5 mg Daily: Insights from the LoDoCo2 Trial

A van Broekhoven, JW Eikelboom, SM Nidorf… - Clinical Drug …, 2023 - Springer
Colchicine 0.5 mg once daily reduces the risk of major adverse cardiovascular events in
patients with coronary disease [1, 2]. The randomized trials that established the efficacy of …

[引用][C] Kolkicin till statinbehandlad patient

S Spørsmål, O RELIS, R Midt-Norge, R Vest…

Colchicine gastrotoxicity in a patient with chronic kidney disease

GCH Ho, WH Lau, MH Leung - Rheumatology, 2019 - academic.oup.com
A 72-year-old man presented with upper gastrointestinal bleeding. He had hyperlipidaemia,
gout and chronic kidney disease (calculated glomerular filtration rate 22ml/min/1.73 m2) …

Is colchicine safe for cardiovascular indications?

M Imazio, A Andreis, F Piroli, M Casula… - European Heart …, 2021 - academic.oup.com
Background Colchicine has an emerging role in the cardiovascular field (eg acute and
chronic coronary syndromes, pericarditis, atrial fibrillation), although, concerns for side …

A systematic review of the drug–drug interaction between statins and colchicine: patient characteristics, etiologies, and clinical management strategies

NC Schwier, CK Cornelio… - … : The Journal of Human …, 2022 - Wiley Online Library
Colchicine and statins are frequently co‐prescribed for prevention and treatment of
cardiovascular diseases, auto‐inflammatory diseases, and gout. Both are substrates and …

[HTML][HTML] Myopathy caused by the interaction of colchicine and statins

AS Kazakov, MA Darmostukova, TM Bukatina… - Safety and Risk of …, 2018 - risksafety.ru
Myopathy is a life-threatening disease that can be caused, among other things, by the intake
of various medications. Despite the fact that many drug-induced myopathies are well known …

Colchicine: An ancient drug with multiple benefits

G El Hasbani, A Jawad, I Uthman - Current Pharmaceutical …, 2021 - ingentaconnect.com
The history of colchicine dates to ancient Egyptians when it was used for alleviation of
swelling and pain. Although its popularity varied throughout the years, colchicine has been a …

Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease

Y Solak, SB Acikgoz, M Yildirim - Clinical drug investigation, 2015 - Springer
We read the article by Wason et al.[1] with great enthusiasm. The authors conducted an
elaborate study in which they investigated colchicine pharmacokinetics in subjects with …

Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease

S Wason, D Mount, R Faulkner - Clinical drug investigation, 2014 - Springer
Abstract Background and Objective The effect of renal impairment on colchicine
pharmacokinetics in patients with chronic kidney disease (CKD) has not been studied …

Colchicine toxicity: an exaggerated reality?

Y Solak, SB Acikgoz, M Yildirim - The American journal of medicine, 2015 - amjmed.com
With great interest, we read the review article entitled “Colchicine: Old and New” by
Slobodnick et al. 1 The authors reviewed the general pharmacokinetic properties of …